Home/Pipeline/ARNA-1

ARNA-1

Pan-Cancer Detection

ResearchActive

Key Facts

Indication
Pan-Cancer Detection
Phase
Research
Status
Active
Company

About ARNA Genomics

ARNA Genomics is a private, pre-revenue diagnostics company developing a proprietary liquid biopsy platform for early cancer detection. Its lead program, ARNA Breast, is an assay for early-stage breast cancer currently in development and clinical trials. The company boasts a scientifically distinguished leadership team, including inventor Anatoly Melnikov and renowned scientist Dr. Charles R. Cantor, and is headquartered in Orange County, California.

View full company profile

Therapeutic Areas